2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Molecular Testing, Clinical Procedures, Treatment Considerations, Combination Therapy, Supportive Care, Therapy Sequence, Biological Therapies, Transplantation, Bispecific Antibody Therapy, Chimeric Antigen Receptor, (CAR)-T Cell Therapies, Immunotherapy, Non-Biological Therapies, Chemotherapy, Surgical, Workforce, Adverse Events, Artificial Intelligence (AI), Generative AI, Natural Language Processing, Biological Processes, Molecular Biology, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Telemedicine, Value, Diseases, Lymphoid Malignancies, Lymphoid Leukemias, Lymphomas, Plasma Cell Disorders, Measurable Residual Disease, ALL, CLL, Non-Hodgkin Lymphoma, B Cell Lymphoma, Aggressive Lymphoma, Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Elderly, Pediatric, Young Adult
PAPER

6159 Medical mistrust and challenging relationships with providers among caregivers of children with cancer

Kristine Karvonen, MD, MS, Astan Jeyte2, David R Doody, MS3, Rahel Behailu, MPH4, Kayla L Karvonen, MD, MAS5, Tim JD Ohlsen, MD, MS6, Molly Taylor, MD, MS7, Kira Bona, MD, MPH8, Jason A Mendoza, MD, MPH9, Eric J Chow, MD, MPH10
1 Fred Hutchinson Cancer Center, Seattle, Washington, United States, Seattle Children’s Research Institute, Seattle, Washington, United States, University of Washington School of Medicine, Seattle, Washington, United States
2 Seattle Children’s Research Institute, Seattle, Washington, United States
3 Fred Hutchinson Cancer Center, Seattle, Washington, United States
4 YMCA of the Greater Seattle, Seattle, United States
5 University of California San Francisco, San Francisco, California, United States
6 Seattle Children’s Research Institute, Seattle, Washington, United States, University of Washington School of Medicine, Seattle, Washington, United States
7 Seattle Children’s Research Institute, Seattle, Washington, United States, University of Washington School of Medicine, Seattle, Washington, United States
8 Harvard Medical School, Boston, Massachusetts, United States
9 Fred Hutchinson Cancer Center, Seattle, Washington, United States, University of Washington School of Medicine, Seattle, Washington, United States
10 Fred Hutchinson Cancer Center, Seattle, Washington, United States, Seattle Children’s Research Institute, Seattle, Washington, United States, University of Washington School of Medicine, Seattle, Washington, United States

Introduction: Medical mistrust and challenging relationships with providers are associated with adverse health outcomes and are disproportionately experienced by historically minoritized racial and ethnic groups. Although racial/ethnic survival disparities experienced by children with cancer are well documented, potential mediators such as medical mistrust, challenging relationships, and experienced discrimination in this setting are rarely collected and are poorly understood. We hypothesized that minoritized racial and ethnic groups would report more medical mistrust and challenging relationships than Non-Hispanic White (NHW) caregivers, and that experienced medical discrimination would independently predict medical mistrust and challenging relationships with providers among caregivers of children with cancer.

Methods: To characterize mistrust and challenging relationships among caregivers of children with cancer treated at a large standalone children’s hospital, we conducted a cross-sectional study from 7/2024 to 5/2026. All but NHW racial/ethnic groups were selectively recruited using stratified disproportionate sampling. Participants completed the Discrimination in Medical Settings Scales (DMS; primary exposure), Group-Based Medical Mistrust Scale (GBMMS; primary outcome), and Challenging Relationships with Providers (primary outcome). Mistrust was defined as a GBMMS score within the highest mistrust quartile (total possible score 0-48), challenging relationships as any response in the 2 lowest of 4 possible categories (total possible score 0-33) and DMS score >0 (total possible score 0-28). Multivariable associations for mistrust and challenging relationships were separately estimated using marginalized logistic regression and presented as estimated ratios of marginal predicted prevalence with confidence intervals. Covariates were selected a priori, informed by previous literature and then refined based on model fit. Final model covariates included age, gender, race/ethnicity, rurality, and language (for mistrust only) or education (for challenging relationships only).

Results: Overall, 182 caregivers were approached, 122 were enrolled, and 111 caregivers completed surveys. Most caregivers were 35-44 years old (57.7%) and female (76.6%). Caregivers identified as Hispanic (34.2%), NHW (24.3%), Asian (14.4%), American Indian/Alaska Native (9.9%), Black (9.9%), and Pacific Islander or Middle Eastern/North African (7.2%). A quarter of caregivers reported any mistrust; the median score among these participants was 23.5 (Interquartile Range [IQR]: 20.5-25.5). Participants most frequently reported medical mistrust by disagreeing with ‘in most hospitals, people of different ethnic groups receive the same kind of care’, people of my ethnic group ‘receive the same medical care from doctors and other healthcare workers as people from other groups’ and ‘are treated the same as people from other groups by doctors and healthcare workers’ (26.4%, 24.3%, 22.5%, respectively). Among the 35 (31.5%) caregivers who reported challenging relationships, the median score was 6 (IQR: 4-11). The most common challenging relationships aspects included feeling ‘you have to push your child’s oncology provider to make sure your child is receiving the best possible care’, concern ‘your child’s oncology provider may make mistakes that could affect your child’s care’, and not believing ‘your child’s oncology provider is sensitive to your feelings’ (17.1%, 10.9%, 8.1%, respectively). Black caregivers were 3.3 (95%CI: 1.2-9.3) times more likely than NHW caregivers to report mistrust, and caregivers who identified as Hispanic and Pacific Islander or Middle Eastern/North African were 3.3 (95%CI: 1.1-10.3) and 4.3 (95%CI: 1.3-14.4) times more likely to report challenging relationships. Caregivers who reported any medical discrimination were 5.0 (95% CI: 2.0-12.6) times more likely to report mistrust and 2.0 (95% CI: 1.1-3.8) times more likely to report challenging relationships than those without experienced discrimination.

Discussion: This single-site study suggests medical mistrust and challenging relationships with providers are relatively common and disproportionately burdened by racially minoritized caregivers of children with cancer. Medical discrimination may be a relevant upstream target to address medical mistrust, challenging relationships, and survival disparities in pediatric oncology.

Kristine Karvonen, MD, MS: No relevant conflicts of interest to declare.